Loading insider details...
Beta
Latest Form 4 (Oct 2, 2026): Sale of 30,000 ORMP shares, $135.3K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Oct 2, 2026 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale | 30,000 | $135.3K |
| Sep 25, 2026 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/Award | 75,455 | n/a |
| Jul 2, 2026 | ORAMED PHARMACEUTICALS INC. (ORMP) | Sale | 137,000 | $611.4K |
| Mar 18, 2026 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/Award | 95,889 | n/a |
| Jan 29, 2026 | ORAMED PHARMACEUTICALS INC. (ORMP) | Exercise/Conversion | 19,000 | n/a |
| Jan 5, 2026 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/Award | 97,328 | n/a |
| Feb 11, 2025 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/Award | 45,000 | n/a |
| Jan 6, 2025 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/Award | 194,500 | n/a |
| Nov 8, 2024 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/Award | 30,000 | n/a |
| Jan 8, 2024 | ORAMED PHARMACEUTICALS INC. (ORMP) | Grant/Award | 180,500 | n/a |